Breast cancer research in the era of precision medicine
Yang Haiyuan;,Jiang Yizhou;,Shao Zhiming;

..............page:401-403

Overexpression of Keap1 inhibits the cell proliferation and metastasis and overcomes the drug resistance in human lung cancer A549 cells
Weng Xu;,Yan Youyou;,Tong Yinghui;,Fan Yun;,Zeng Jianmei;,Wang Linling;,Lin Nengming;

..............page:404-410

Mifepristone inhibites the migration of endometrial cancer cells through regulating H19 methylation
Lu Zhenzhen;,Yan Lei;,Zhang Hui;,Li Mingjiang;,Zhang Xiaohui;,Zhao Xingbo;

..............page:411-416

Effect of autophagy inhibitor combined with EGFR inhibitor on triple-negative breast cancer MDA-MB-468 and MDA-MB-231 cells
Liu Zhaoyun;,He Kewen;,Song Xingguo;,Wang Xinzhao;,Zhuo Peiying;,Wang Xingwu;,Ma Qinghua;,Huo Zhijun;,Yu Zhiyong;

..............page:417-424

Regulatory effect and mechanism of RNA binding motif protein 38 on the expression of progesterone receptor in human breast cancer ZR-75-1 cell
s Lou Peipei;,Li Chunlian;,Xia Tiansong;,Shi Liang;,Wu Jing;,Zhou Xujie;,Wang Ying;,Ding Qiang;

..............page:425-429

Expression of microRNA-29b in colorectal cancer and its relationship with clinicopathological features
Ma Xiao;,Yuan Wei;,Tang Wanyan;,Ma Jie;

..............page:430-433

Application of diffusion-weighted intravoxel incoherent motion imaging in diagnosis of renal cell carcinoma subtypes
Cong Xinying;,Chen Yan;,Zhang Jin;,Yu Xiaoduo;,Ye Feng;,Yu Weijun;,Zhang Miaomiao;,Ouyang Han;,Zhao Xinming;

..............page:434-439

yi xue ke yan lun wen zhong a la bo shu zi de shi yong gui ze

..............page:439-439

Prognostic differences of phenotypes in pT1-2N0 invasive breast cancer：a large cohort study with cluster analysis
Wang Zhi;,Wang Weihu;,Wang Shulian;,Jin Jing;,Song Yongwen;,Liu Yueping;,Ren Hua;,Fang Hui;,Tang Yu;,Chen Bo;,Qi Shunan;,Lu Ningning;,Li Ning;,Tang Yuan;,Liu Xinfan;,Yu Zihao;,Li Yexiong;

..............page:440-447

ben kan dui lai gao zhong tong ji xue chu li de you guan yao qiu

..............page:447-447

Clinicopathological features and prognosis of HER2-negative luminal-type breast cancer patients with early and late recurrence
Chen Xuelian;,Fan Ying;,Xu Binghe;

..............page:448-453

ben kan yu fang yan jiu lan mu zheng gao qi shi

..............page:453-453

Efficiency and adverse effects of the effective therapy applying etoposide + cisplatin and its subsequent maintenance therapy with different durations in patients with small cell lung cancer
Yang Changliang;,Ma Lixia;,Sun Shuangyan;,Cui Hongxia;,Li Zili;,Cheng Ying;

..............page:454-459

Survival after surgical treatment of bilateral synchronous multiple primary non-small cell lung cancers
Zhang Zhirong;,Mao Yousheng;,Gao Shugeng;,Mu Juwei;,Xue Qi;,Wang Dali;,Gao Yushun;,Zhao Jun;,He Jie;

..............page:460-465

guan yu yi gao liang tou he zhong fu fa biao wen ti de chu li yuan ze

..............page:465-465

Analysis of the survival of 123 patients with intrahepatic cholangiocarcinoma after surgical resection
Bi Chao;,Wang Liming;,An Songlin;,Huang Jing;,Feng Ruimei;,Wu Fan;,Rong Weiqi;,Wu Jianxiong;

..............page:466-471

2015 nian du zhong hua zhong liu za zhi you xiu lun wen ping xuan jie guo jie xiao

..............page:471-471

Efficacy observation of 125 I seed implantation therapy for locoregional recurrent and metastatic breast cancer
Yi Fuxiang;,Yu Yinghua;,Wei Changyuan;,Yang Weiping;,Qin Qinghong;,Tan Qixing;,Mo Qinguo;,Huang Zhen;,Lian Bin;

..............page:472-475

Polymorphism at the miR-502 binding site in the 3′ untranslated region of SET8 gene is associated with the risk of clear cell renal cell carcinoma
Xu Jinsheng;,Bai Yaling;,Zhang Junxia;,Cui Liwen;,Zhang Huiran;,Zhang Shenglei;

..............page:476-479

Crizotinib for anaplastic large-cell lymphoma relapsed after autologous stem cell transplantation：a case report
Zhou Ying;,Yu Gengsheng;

..............page:479-480